Alternatives for malaria prophylaxis during the first trimester of pregnancy: Our personal view

Journal of Travel Medicine

Volumn 17, Issue 2, 2010, Pages 130-132

  Hellgren, Urban ^a   Rombo, Lars ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Center for Clinical Research Sormland County Council   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; DOXYCYCLINE; MEFLOQUINE; QUININE DERIVATIVE; TETRACYCLINE DERIVATIVE;

ACNE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONGENITAL MALFORMATION; DRUG EXPOSURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; ENVIRONMENTAL EXPOSURE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFECTION; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; PREGNANT WOMAN; RECOMMENDED DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STILLBIRTH; TERATOGENICITY; TOOTH DISCOLORATION; TRAVEL;

ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; FEMALE; HUMANS; MALARIA; MEFLOQUINE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; SWEDEN; TETRACYCLINES;

EID: 77649256194     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2009.00380.x     Document Type: Review

References (22)

1. Oakley GP Jr. Frequency of human congenital malformations. Clin Perinatol 1986 13 : 545 554.
2. Hook EB, Regal RR. Representative and misrepresentative associations of birth defects in livebirths. Am J Epidemiol 1993 137 : 660 675.
3. Fischer B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clin Obstet Gynecol 2008 51 : 106 118.
4. World Health Organisation. WHO International Travel and Health. 2009 p. 163. Available at: www.who.int/ith/ITH2009Chapter7.pdf.
5. GlaxoSmith Kline (Rixensart, Belgium). Section 4.6. Malarone in pregnancy. Available at http://emc.medicines.org.uk/medicine/756/SPC/Malarone/ #PREGNANCY. (Accessed 2009 May 31).
6. McGready R, Ashley EA, Moo E, et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis 2005 192 : 846 853.
7. Roche. Lariam. Basel, Switzerland. Available at: http://www.rocheusa.com/ products/lariam/pi.pdf. (Accessed 2009 May 31)
8. World Health Organisation. WHO International Travel and Health, 2009. p 159. Available at: www.who.int/ith/ITH2009Chapter7.pdf.
9. Centers for Disease Control and Prevention. Atlanta, USA. CDC health information for international travel 2009. Available at: http://www.cdc.gov./ travel/Yellow book Chapter 4 malaria. (Accessed 2009 May 31).
10. Freedman DO. Malaria prevention in short term travellers. N Engl J Med 2008 359 : 603 612.
11. Wiltz SA, Crawford P, Nichols W, Hayes M. Clinical inquiries. What is the most effective and safe malaria prophylaxis during pregnancy? J Fam Pract 2008 57 : 51 53.
12. Vanhauwere B, Maradit H, Kerr L. Post-marketing surveillance of prophylactic mefloquine (Lariam®) use in pregnancy. Am J Trop Med Hyg 1998 58 : 17 21.
13. Schlagenhauf P, Boutros MS, Leuenberger T, Frohlich E. Use of mefloquine chemoprophylaxis by nonimmune travellers before and during pregnancy. A critical evaluation of the evidence. Northern European Conference in Travel Medicine; Edinburgh, Scotland 2006 [Abstract O-9].
14. Nosten F, Vincenti M, Simpson J, et al. The effects of mefloquine treatment in pregnancy. Clin Infect Dis 1999 28 : 808 815.
15. Steketee RW, Wirima JJ, Slutsker L, et al. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Am J Trop Med Hyg 1996 55 : 50 56.
16. Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006 107 : 1120 1138.
17. Czeizel AE, Puhó EH, Acs N, Bánhidy F. Use of specified critical periods of different congenital abnormalities instead of the first trimester concept. Birth Defects Res Part A 2008 82 : 139 146.
18. Briggs GG. Drug effects on the fetus and breast-fed infant. Clin Obstet Gynecol 2002 45 : 6 21.
19. The Swedish Association of the Pharmaceutical Industry. Doxycyklin och graviditet. Available at: www.fass.se/LIF/produktfakta/artikel-produkt.jsp? NplID=19930319000041&DocTypeID=7&UserTypeID=2 (Accessed 2009 May 31).
20. Czeizel A, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol 1997 89 : 524 528.
21. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. 5th Ed. Baltimore, MD : Williams & Wilkins, 1997 1011 1013.
22. Swedish Institute for Infectious Disease Control. Rekommendationer för malariaprofylax. 2008. Available at: www.smittskyddsinstitutet.se. (Accessed 2009 May 31).